Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

AIMS: To evaluate the pharmacokinetics, safety and tolerability of single and multiple oral doses of maraviroc in healthy volunteers. METHODS: Three double-blind, placebo-controlled, dose-escalation studies with either single or multiple doses of maraviroc were conducted in healthy volunteers. Plasm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Abel, Samantha, van der Ryst, Elna, Rosario, Maria C, Ridgway, Caroline E, Medhurst, Christine G, Taylor-Worth, Richard J, Muirhead, Gary J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2008
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2311414/
https://ncbi.nlm.nih.gov/pubmed/18333861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03130.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak